Pairing JAK With MEK for Improved Therapeutic Efficiency in Myeloproliferative Disorders

Journal of Clinical Investigation - United States
doi 10.1172/jci127582
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

JAK Inhibition and Symptom Control in Myeloproliferative Neoplasms

Current Medical Research and Opinion
Medicine
2018English

Sweet Syndrome Successfully Treated With Ruxolitinib in JAK-2 Positive Myeloproliferative Disorder

2018English

Pathogenesis of Myeloproliferative Disorders

Annual Review of Pathology: Mechanisms of Disease
MedicineForensic MedicinePathologyPlant Science
2016English

Von Willebrand Factor in Myeloproliferative Disorders

Blood & Vessel
1980English

Lymphoproliferative Disorders in Patients With Chronic Myeloproliferative Neoplasms: A Systematic Review

American Journal of Hematology
Hematology
2018English

Studies on Platelet Functions in Myeloproliferative Disorders

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1977English

Portal Vein Thrombosis With Cavernous Transformation in Myeloproliferative Disorders: Review Update

2012English

Therapeutic Programs for Students With Behavior Disorders in Public Schools

Journal of Educational Issues
2017English

Energy Efficiency Maximized Resource Allocation for Opportunistic Relay-Aided OFDMA Downlink With Subcarrier Pairing

Wireless Communications and Mobile Computing
Computer NetworksElectronic EngineeringInformation SystemsElectricalCommunications
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy